Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus (Q65333165)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus |
clinical trial |
Statements
OPTIMUS-5 (English)
0 references
Pharmacodynamic Effects of Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus: The Optimizing Anti-Platelet Therapy In Diabetes MellitUS (OPTIMUS)-5 Study (English)
0 references
25 March 2016
0 references
December 2018
0 references
64
0 references
18 year
0 references